Millavelez, Chriz June .
HRN: 21-85-33 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2022
CEFTRIAXONE 1G (VIAL)
08/23/2022
08/30/2022
IV
1 G
Q12H
T/CNephrotic Syndrome; R/O Strep Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes